SDB-005 is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. It is presumed to be an agonist of the CB₁ and CB₂ cannabinoid receptors. SDB-005 is the indazole core analog of PB-22 where the 8-hydroxyquinoline has also been replaced with a naphthalene group.

  • Project Type: Paper Design
  • Skills Needed: Photoshop, Illustrator
  • Customer: Example Inc
  • Project Year: 2013